Back to search

Article

Two engineered AAV capsid variants for efficient transduction of human cortical neurons directly converted from iPSC

2021-09-06

Abstract excerpt

Recombinant adeno-associated virus (AAV) is the most widely used vector for gene therapy in clinical trials. To increase transduction efficiency and specificity, novel engineered AAV variants with modified capsid sequences are evaluated in human cell cultures and non-human primates. In the present study, we tested two novel AAV capsid variants, AAV2-NNPTPSR and AAV9-NVVRSSS, in human cortical neurons, which were d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c561f8d8-90cc-5e10-95e1-aa56019469e5
DOI
10.1101/2021.09.06.459070
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Two engineered AAV capsid variants for efficient transduction of human cortical neurons directly converted from iPSCDOI 10.1101/2021.09.06.459070
Select a neighboring publication to make it the new centre.